Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver
about
Large-scale cDNA transfection screening for genes related to cancer development and progressionMicroRNAs: control and loss of control in human physiology and diseaseOverexpression of squamous cell carcinoma antigen variants in hepatocellular carcinomaIdentification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray dataElevated creatine kinase activity in primary hepatocellular carcinomaComparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinomaDistinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinomaExpression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomashOLF44, a secreted glycoprotein with distinct expression pattern, belongs to an uncharacterized olfactomedin-like subfamily newly identified by phylogenetic analysisMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsDeleted in liver cancer protein family in human malignancies (Review)Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesisImpact of delay to cryopreservation on RNA integrity and genome-wide expression profiles in resected tumor samplesApg-2 has a chaperone-like activity similar to Hsp110 and is overexpressed in hepatocellular carcinomasRNA-Sequencing data supports the existence of novel VEGFA splicing events but not of VEGFAxxxb isoforms.Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinomaProteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues.Expressed sequence tags from cynomolgus monkey (Macaca fascicularis) liver: a systematic identification of drug-metabolizing enzymes.Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events.Molecular genetics of hepatocellular neoplasia.SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancerIdentification of drivers from cancer genome diversity in hepatocellular carcinoma.Differential gene expression analysis of in vitro duck hepatitis B virus infected primary duck hepatocyte cultures.RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma.Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.Hdac3 is essential for the maintenance of chromatin structure and genome stability.A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas.Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling.Molecular profiling of hepatocellular carcinomas by cDNA microarray.MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomyEmerging roles of E2Fs in cancer: an exit from cell cycle controlAdenovirus-delivered PDCD5 counteracts adriamycin resistance of osteosarcoma cells through enhancing apoptosis and inhibiting Pgp.ChIP-seq in steatohepatitis and normal liver tissue identifies candidate disease mechanisms related to progression to cancer.Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells.Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma.Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.
P2860
Q24561958-C6443D97-FE87-466D-AB86-B01F5291E3B6Q24618771-4FEC18BE-4B3A-4C6C-A275-F26267325C3DQ24645168-22FD528B-5F5E-4D28-845F-F81A6A9449B3Q24803258-EF8C62C4-1DA5-4DC9-8257-BE2CFD1FA66BQ24803678-8C6B758C-7D56-4E5A-B676-BD7848988F71Q24806069-CD375FA1-738B-41C4-9D7B-9D2183DDC1EDQ27489928-508CB900-8AAE-4D47-AF45-D3ED517CA799Q28268815-5A944ABF-CD81-476B-B1FC-1B242F79986DQ28274349-A643F9E6-7072-4E00-8B79-63B7B8EAE280Q28383646-B2755FE5-3323-4DD4-BE21-703A0EFDE1EEQ28387011-9FB60E1A-DE38-446A-90DD-4F89D9D88F5BQ28488081-0A53184C-8EFF-4F78-9B12-FE30D36BF240Q28535315-09D44D85-FCB5-483A-9B4F-F09C835BBF7CQ28573028-7A320BCF-8932-4E68-807B-62A866C5F4B6Q31168175-0839380B-28AF-4351-B6F9-088D6E81CDC1Q33290638-FCF3FC13-991F-493A-86A3-3A164B6437DBQ33290708-0C85E969-D9EB-4055-8272-1B53164B96A8Q33312876-51EBD347-1D77-421F-B06D-3D645A38DF25Q33367131-C6915168-49AB-4DC9-AED9-60BE60DD5DBCQ33469999-1D41AD15-7071-4935-8D0D-AF98FC5943DCQ33680701-11618952-81C3-4674-86A7-3121E9E90DDAQ33683019-9BE2D776-B8F8-44C1-B35F-830FB7BD0D59Q33688583-1AD274BA-345D-470B-A5DE-B807B1A16536Q33771011-7BD5E792-C0D8-4414-B87E-2E9C5BFD2541Q33907993-1AD9520C-A28C-4713-85CF-D96AD3E87EC0Q33969001-1AA9DCD9-2D12-464F-8F52-6B4D4E2B6BA1Q34063655-E97C5B59-591F-4D6B-B3C2-C1B36296ACB0Q34079748-D65DCC57-89AF-47A7-A85A-096C987D0FFBQ34417264-305AA660-90BC-440B-8EA4-B799DC823CB8Q34552640-79321FF7-6431-4B15-A6F0-50A959AD1388Q34576344-A8D0F55B-356F-4BE4-918A-206E4461E24FQ34605680-7AFFCEBC-7F80-4297-ABBC-AAEC19C9EC64Q34675280-1FFB4F5B-64E1-42F2-9D7B-14351669E14CQ34768282-E0C5123B-F442-4740-9AFA-1D3ECA6AC5B4Q35009182-E66829D7-995C-4E44-96EC-3827C3D74AD1Q35017205-36CFCF61-0DB0-4331-934F-50C3469E8521Q35037365-739471F3-304D-4630-B596-D14DAA48B454Q35063797-9154E310-3656-4350-94BD-A89839DC298EQ35109229-40301259-3343-40AE-8F53-B54BA6F411FEQ35170154-8D5004C9-231E-4B10-A1F9-7F7801016DF4
P2860
Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Insight into hepatocellular ca ...... rresponding noncancerous liver
@ast
Insight into hepatocellular ca ...... rresponding noncancerous liver
@en
Insight into hepatocellular ca ...... rresponding noncancerous liver
@nl
type
label
Insight into hepatocellular ca ...... rresponding noncancerous liver
@ast
Insight into hepatocellular ca ...... rresponding noncancerous liver
@en
Insight into hepatocellular ca ...... rresponding noncancerous liver
@nl
prefLabel
Insight into hepatocellular ca ...... rresponding noncancerous liver
@ast
Insight into hepatocellular ca ...... rresponding noncancerous liver
@en
Insight into hepatocellular ca ...... rresponding noncancerous liver
@nl
P2093
P2860
P3181
P356
P1476
Insight into hepatocellular ca ...... rresponding noncancerous liver
@en
P2093
P2860
P304
P3181
P356
10.1073/PNAS.241522398
P407
P577
2001-12-18T00:00:00Z